Latest news with #CIPM
Indian Express
20-05-2025
- General
- Indian Express
World Metrology Day 2025: Date, theme, origin, significance — all you need to know
World Metrology Day 2025: World Metrology Day is celebrated globally on May 20 every year to highlight the importance of the science of measurement in our daily lives and raise awareness around it. Metrology has constantly pushed scientific and technological advancements; this day highlights metrology's impact on quality of life and conservation of the environment, thereby aligning with UNESCO's objective to advance science for a better world. In 2025, the day is being observed on Tuesday, May 20, with the theme 'Measurements for all times, for all people,' emphasising the critical role measurements play in shaping our history, present, and future. This occasion is particularly meaningful in 2025 as it marks the 150th anniversary of the Metre Convention, an international agreement that formally established the metric system to ensure consistency and fairness in research measurements and unit standardisation worldwide. The celebration, initiated in 1999 by the International Committee for Weights and Measures (CIPM), honours the Metre Convention signed in Paris on May 20, 1875. Every year, national metrology institutes, legal metrology authorities, regional organisations, and a wide range of stakeholders from more than 50 countries engage in the festivities.
Associated Press
07-02-2025
- Business
- Associated Press
Marquis Who's Who Honors Michael Stigall's Dedication to Laboratory Automation System Evaluation
UNIONDALE, NY / ACCESS Newswire / February 6, 2025 / Michael Stigall has been selected by Marquis Who's Who for his work in laboratory automation system evaluation. His extensive career has spanned various industries, including pharmaceuticals, biotechnology and finance. Mr. Stigall's expertise includes regulatory compliance, quality assurance and project management. For the past 46 years, Mr. Stigall's career has been defined by his relentless pursuit of innovation. With a diverse background spanning chemistry, computer science and project management, Mr. Stigall has carved out a unique niche for himself at the intersection of emerging technologies and regulated industries. Mr. Stigall is a principal validation engineer and consultant at USDM Life Sciences, specializing in pharmaceutical and biotechnology laboratory systems. Mr. Stigall's path in the tech world is the definition of unconventional. Originally armed with a master's degree in chemical engineering and a bachelor's degree in chemistry and German, he started his career with artificial intelligence (AI) projects long before the technology became mainstream. He would later explore different industries, including specialty chemicals, oil and gas, railroads, biotechnology and pharmaceuticals. However, his passion for new technologies in the AI space remained. 'I enjoy following new technology and finding new application areas for artificial intelligence,' Mr. Stigall explains. Pursuing his passions, he has amassed an impressive array of certifications, including Project Management Professional (PMP), Certified Information Privacy Manager (CIPM), and numerous programming and system administration accreditations. He has also earned multiple industry awards and recognitions, including his latest, the Albert Nelson Marquis Lifetime Achievement Award, which speaks to his significant contributions to laboratory automation system evaluation and his esteemed reputation. Mr. Stigall's interests go far beyond the confines of the laboratory. Drawing on his early experiences and background in teaching artificial intelligence in Europe, he has turned his attention to the modern AI space and is now exploring its real-world potential. Mr. Stigall is particularly interested in stock market investing, where he believes AI can be a powerful tool for gaining an edge. 'The coming years will be dominated by artificial intelligence,' Mr. Stigall observes. His work in the biotech space has exposed him to AI's disruptive potential and its impact on friends and family members with complex problems such as Hodgkin's Lymphoma and Alzheimer's disease, which were traditionally difficult to manage. 'AI has been a game-changer in the pharmaceutical/biotech industry, and I believe it will continue to revolutionize the field.' Mr. Stigall believes the same effect will be felt in other industries, including investments and finance. The shift has started. According to reports, some investment management firms such as BlackRock have started deploying AI-powered automated investment programs in place of human stock‐pickers. Meanwhile, regulators and stock market investors have embraced high-frequency trading (HFT) and algo-trading, also powered by artificial intelligence. Mr. Stigall sees this as the natural progression in the current stock investment space. 'AI can identify patterns and detect issues that require attention with greater accuracy than humans,' he notes. Mr. Stigall hopes to play a major role in this revolution through consulting and thought leadership. His goal is to contribute to a world where AI-powered business processes are the norm, empowering organizations to push the boundaries of what they thought possible. About Marquis Who's Who®: Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, .
